Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-21

Clinical Trial Update: Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial updated results on switching from ticagrelor to clopidogrel in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)
  • TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Florida | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2020-08-21